{
    "clinical_study": {
        "@rank": "36808", 
        "arm_group": [
            {
                "arm_group_label": "Continuous administration of Entonox", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients randomized to this arm will be asked to inhale Entonox throughout the insertion phase of colonoscopy"
            }, 
            {
                "arm_group_label": "As required administration of Entonox", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients randomised to this arm will be asked to use Entonox if and when they have pain"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will randomise patients undergoing screening colonoscopy to receive Entonox\n      either continuously or as required.\n\n      Both these methods are used in the published studies of Entonox and in clinical practice.\n\n      Null hypothesis There will be no difference in pain levels between these two methods of\n      Entonox administration"
        }, 
        "brief_title": "Optimizing the Use of Entonox\u00ae During Screening Colonoscopy", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Bowel Cancer Screening", 
            "Analgesia", 
            "Entonox", 
            "Colonoscopy"
        ], 
        "condition_browse": {
            "mesh_term": "Intestinal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Having a bowel cancer screening programme colonoscopy\n\n        Exclusion Criteria:\n\n          -  Contraindications to Entonox\n\n          -  Previous bowel resections"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "198", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01865721", 
            "org_study_id": "STH16359", 
            "secondary_id": "2012-003342-33"
        }, 
        "intervention": {
            "arm_group_label": [
                "Continuous administration of Entonox", 
                "As required administration of Entonox"
            ], 
            "description": "Entonox will be used according to the allocated method", 
            "intervention_name": "Entonox", 
            "intervention_type": "Drug", 
            "other_name": "Entonox"
        }, 
        "intervention_browse": {
            "mesh_term": "Entonox"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Bowel cancer screening", 
            "Analgesia", 
            "Entonox", 
            "Pain", 
            "Side effects", 
            "Colonoscopy"
        ], 
        "lastchanged_date": "November 29, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sheffield", 
                    "country": "United Kingdom", 
                    "state": "South Yorkshire", 
                    "zip": "S5 7AU"
                }, 
                "name": "Sheffield Teaching Hospitals NHS Foundation Trust"
            }, 
            "investigator": [
                {
                    "last_name": "Alex J Ball, MB ChB", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Stuart A Riley, MB ChB", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Optimizing the Use of Entonox\u00ae During Screening Colonoscopy: an Open Randomised Controlled Trial", 
        "overall_contact": {
            "email": "stuart.riley@sth.nhs.uk", 
            "last_name": "Stuart A Riley, MB ChB", 
            "phone": "01142434343"
        }, 
        "overall_official": {
            "affiliation": "Sheffield Teaching Hospital", 
            "last_name": "Stuart A Riley, MB ChB", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patients will be asked about their overall recollection of pain on a 10 point numerical ratings scale prior to discharge", 
            "measure": "Pain scores", 
            "safety_issue": "No", 
            "time_frame": "Day 1: Prior to discharge from endoscopy department"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01865721"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Patients will be asked about their experience of pain during colonoscopy. In addition patients will be asked about their overall recollection of pain immediately after colonoscopy and 1-3 days following colonoscopy.", 
                "measure": "Pain scores", 
                "safety_issue": "No", 
                "time_frame": "Day 1-4: Prior to discharge and 1-3 days later"
            }, 
            {
                "description": "Patients additional use of sedation and analgesia will be compared in each treatment arm", 
                "measure": "Use of analgesia and sedation", 
                "safety_issue": "No", 
                "time_frame": "Day 1: During colonoscopy"
            }, 
            {
                "description": "Patients will be asked about their overall level of satisfaction immediately prior to discharge and 1-3 days later", 
                "measure": "Patients satisfaction", 
                "safety_issue": "No", 
                "time_frame": "Day 1-4: Prior to discharge and 1-3 days later"
            }, 
            {
                "description": "Patients will be asked about their willingness to have a repeat colonoscopy prior to discharge and 1-3 days following colonoscopy", 
                "measure": "Willingness to have a repeat colonoscopy", 
                "safety_issue": "No", 
                "time_frame": "Day 1: Prior to discharge"
            }, 
            {
                "description": "Patients will be asked about the presence of side effects during colonoscopy. This will be quantified according to whether it limited the use Of Entonox.", 
                "measure": "Side Effects", 
                "safety_issue": "No", 
                "time_frame": "Day 1: During colonoscopy"
            }
        ], 
        "source": "Sheffield Teaching Hospitals NHS Foundation Trust", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sheffield Teaching Hospitals NHS Foundation Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}